| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $9K | — | -87.5% |
| SG&A Expense | $556K | — | +23.3% |
| Operating Income | -$565K | — | -7.6% |
| Pre-tax Income | $219K | — | +140.5% |
| Net Income | $219K | — | +140.5% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $18K | — | — |
| Short-term Investments | $175K | — | — |
| Inventory | $5K | +0.0% | +48.6% |
| Current Assets | $255K | +7.2% | +1.0% |
| Total Assets | $1.3M | +410.9% | +400.0% |
| Current Liabilities | $5.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$153K | — | -70.5% |
| Financing Cash Flow | $171K | — | +72.0% |
| — |
| +14.2% |
| +76.1% |
| Total Liabilities | $5.3M | +14.2% | +76.1% |
| Stockholders' Equity | -$4.0M | +8.2% | -46.4% |